Additional file 1: Table S1. of CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

Authors :: Pinto-Mariz, Fernanda
Carvalho, Luciana Rodrigues
Araujo, Alexandra Prufer De Queiroz Campos
Mello, Wallace De
MĂĄrcia GonĂ§Alves Ribeiro
Cunha, Maria
Cabello, Pedro
Riederer, Ingo
Negroni, Elisa
Desguerre, Isabelle
Veras, Mariana
Yada, Erica
Allenbach, Yves
Benveniste, Olivier
Voit, Thomas
Mouly, Vincent
Silva-Barbosa, Suse
Butler-Browne, Gillian
Savino, Wilson
Publisher :: Figshare
Abstract: General characteristics of the DMD patients enrolled in the study of blood samples. (DOC 35 kb)

Subjects :: musculoskeletal diseases
congenital, hereditary, and neonatal diseases and abnormalities
nervous system diseases
3. Good health

Tools